Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Thorax 2005;60:709a; doi:10.1136/thx.2005.awsep
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedzicha, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wedzicha, W.
Topic Collections
Right arrowRelated Articles

Airwaves

Wisia Wedzicha, Editor in Chief

The first 150 words of the full text of this article appear below.


AMINOPHYLLINE AT COPD EXACERBATIONS
More effective treatment of COPD exacerbations is an important goal of COPD therapy. A number of guidelines have suggested that intravenous aminophylline can be used to treat COPD exacerbations when the response to usual treatment is inadequate. However, the evidence for this option is weak and the few previous trials of aminophylline at exacerbation have been small and generally underpowered for relevant outcomes. In this month’s Thorax, Duffy and colleagues report the first adequately powered randomised trial of intravenous aminophylline in 80 patients admitted to hospital with COPD exacerbations, and the study is discussed in the accompanying editorial by Town. The study found that the addition of intravenous aminophylline to nebulised bronchodilators and oral corticosteroids in non-acidotic exacerbations produced small improvements in acid-base balance, but there was no effect on the subsequent clinical course. There were no benefits on the severity of breathlessness or length of hospital stay between . . . [Full text of this article]


Related Articles

Aminophylline for COPD exacerbations? Not usually
G I Town
Thorax 2005 60: 709. [Extract] [Full Text] [PDF]

When should a long acting ß agonist be added to an inhaled corticosteroid?
A E Tattersfield
Thorax 2005 60: 710. [Extract] [Full Text] [PDF]

Glucose, bronchial secretions and MRSA
J S Brown
Thorax 2005 60: 711-712. [Extract] [Full Text] [PDF]

Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma
M Masoli, M Weatherall, S Holt, and R Beasley
Thorax 2005 60: 730-734. [Abstract] [Full Text] [PDF]

Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients
B J Philips, J Redman, A Brennan, D Wood, R Holliman, D Baines, and E H Baker
Thorax 2005 60: 761-764. [Abstract] [Full Text] [PDF]

Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial
N Duffy, P Walker, F Diamantea, P M A Calverley, and L Davies
Thorax 2005 60: 713-717. [Abstract] [Full Text] [PDF]

Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease
I Vogiatzis, O Georgiadou, S Golemati, A Aliverti, E Kosmas, E Kastanakis, N Geladas, A Koutsoukou, S Nanas, S Zakynthinos, and Ch Roussos
Thorax 2005 60: 723-729. [Abstract] [Full Text] [PDF]

Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation
A H Nickol, N Hart, N S Hopkinson, J Moxham, A Simonds, and M I Polkey
Thorax 2005 60: 754-760. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society